Smart brain pacemaker learns to adjust itself for Parkinson's patients
NCT ID NCT07682311
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study tests a new automated method to fine-tune adaptive deep brain stimulation (aDBS) for people with Parkinson's disease. aDBS uses brain signals to adjust stimulation in real time, but setting it up is complex. The trial will compare automated aDBS to standard continuous DBS in 40 adults aged 25-75 who already have a Medtronic Percept DBS device. The goal is to see if the automated approach reduces bothersome movement symptoms and improves quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- adaptive deep brain stimulation (aDBS) using the Medtronic Percept device
- What this could lead to
- If successful, this could make adaptive DBS easier to set up and more effective for people with Parkinson's, potentially reducing daily movement problems and improving quality of life.
- What could go wrong
- This is a small, early-stage study (40 people) testing a new automated tuning method. It may not work for everyone, and the benefits seen here might not hold up in larger, longer-term trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PD - PARKINSON'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California San Francisco
RECRUITINGSan Francisco, California, 94107, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.